SHARON DEL ROSARIO-AQUINO: Open Payments
NPI 1457997793 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$525 in 19 payments from 12 companies in 2025. Trend: 2023 $1,125 · 2024 $391 · 2025 $525
Food & beverage: $525
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $122 |
| Novo Nordisk Inc | 3 | $69 |
| Vanda Pharmaceuticals Inc. | 2 | $68 |
| Exact Sciences Corporation | 2 | $44 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $37 |
| Lilly USA, LLC | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Forte Bio-Pharma LLC | 1 | $27 |
| PFIZER INC. | 1 | $26 |
| Mannkind Corporation | 1 | $25 |
Products named: Kerendia, FANAPT, Ozempic, Cologuard Collection Kit, CAPLYTA, PROLATE, NURTEC ODT, AFREZZA.
Industry payments across NV — which companies pay providers there.
